Sionna Therapeutics (SION) Institutional Ownership $20.91 0.00 (0.00%) As of 08/14/2025 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sionna Therapeutics (NASDAQ:SION)Number ofInstitutional Buyers(last 12 months)26TotalInstitutional Inflows(last 12 months)$271.72MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.95M Get SION Insider Trade Alerts Want to know when executives and insiders are buying or selling Sionna Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SION Institutional Buying and Selling by Quarter Sionna Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025Viking Global Investors LP3,195,181$55.44M0.2%+8.2%7.239% 8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.6,747$117K0.0%N/A0.015% 8/14/2025The Manufacturers Life Insurance Company 38,038$660K0.0%+13.4%0.086% 8/13/2025 Bosun Asset Management LLC16,975$295K0.1%N/A0.038% 8/13/2025 New York State Common Retirement Fund6,800$118K0.0%N/A0.015% 8/13/2025 Virtus Investment Advisers LLC5,535$96K0.0%N/A0.013% 8/12/2025 Prudential Financial Inc.135,185$2.35M0.0%+114.6%0.306% 8/12/2025 Rhumbline Advisers17,670$307K0.0%N/A0.040% 8/12/2025 JPMorgan Chase & Co.2,221,188$38.54M0.0%+2.4%5.034% 8/8/2025 Police & Firemen s Retirement System of New Jersey2,608$45K0.0%N/A0.006% Get the Latest News and Ratings for SION and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sionna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2025 Geode Capital Management LLC289,275$5.02M0.0%+113.4%0.656% 8/1/2025 Jennison Associates LLC752,800$13.06M0.0%-12.5%1.706% 7/28/2025 TD Asset Management Inc49,966$867K0.0%-9.8%0.113% 7/24/2025 Aberdeen Group plc950,547$16.49M0.0%+27.4%2.154% 6/27/2025Goldman Sachs Group Inc.63,741$667K0.0%N/A0.144% 5/23/2025 Siren L.L.C.325,000$3.40M0.2%N/A0.737% 5/16/2025Woodline Partners LP80,000$837K0.0%N/A0.181% 5/16/2025Zimmer Partners LP237,500$2.48M0.0%N/A0.538% 5/16/2025Goldman Sachs Group Inc.63,741$667K0.0%N/A0.144% 5/16/2025Alyeska Investment Group L.P.186,222$1.95M0.0%N/A0.422% 5/15/2025RA Capital Management L.P.10,445,322$109.26M1.8%N/A23.673% 5/15/2025Baker BROS. Advisors LP400,000$4.18M0.1%N/A0.907% 5/15/2025TPG GP A LLC6,684,962$69.93M1.4%N/A15.150% 5/15/2025Driehaus Capital Management LLC328,889$3.44M0.0%N/A0.745% 5/15/2025 Siren L.L.C.325,000$3.40M0.2%N/A0.737% 5/14/2025 Atlas Venture Life Science Advisors LLC3,694,020$38.64M7.4%N/A8.372% 5/13/2025 Aberdeen Group plc745,964$7.80M0.0%N/A1.691% 5/9/2025 CenterBook Partners LP114,284$1.20M0.1%N/A0.259% 5/9/2025 Charles Schwab Investment Management Inc.64,644$676K0.0%N/A0.147% 5/7/2025 TD Asset Management Inc55,366$579K0.0%N/A0.125% 5/5/2025 Jennison Associates LLC859,927$9.00M0.0%N/A1.949% (Data available from 1/1/2016 forward) SION Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SION shares? During the previous two years, 26 institutional investors and hedge funds held shares of Sionna Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($109.26M), TPG GP A LLC ($69.93M), Viking Global Investors LP ($55.44M), Atlas Venture Life Science Advisors LLC ($38.64M), JPMorgan Chase & Co. ($38.54M), Aberdeen Group plc ($16.49M), and Jennison Associates LLC ($13.06M).Learn more on Sionna Therapeutics' institutional investors. Which institutional investors have been buying Sionna Therapeutics' stock? Of the 26 institutional investors that purchased Sionna Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($10.45M), TPG GP A LLC ($6.68M), Atlas Venture Life Science Advisors LLC ($3.69M), Aberdeen Group plc ($950.55K), Jennison Associates LLC ($859.93K), Siren L.L.C. ($650K), and Baker BROS. Advisors LP ($400K). How much institutional buying is happening at Sionna Therapeutics? Institutional investors have bought a total of 25,459,902 shares in the last 24 months. This purchase volume represents approximately $271.72M in transactions. Which of Sionna Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold Sionna Therapeutics stock in the last 24 months: Jennison Associates LLC ($107.13K), and TD Asset Management Inc ($5.40K). How much institutional selling is happening at Sionna Therapeutics? Institutional investors have sold a total of 112,527 shares in the last 24 months. This volume of shares sold represents approximately $1.95M in transactions. Related Companies SRRK Major Shareholders MIRM Major Shareholders MOR Major Shareholders HCM Major Shareholders IMVT Major Shareholders KYMR Major Shareholders RARE Major Shareholders CRNX Major Shareholders XENE Major Shareholders NAMS Major Shareholders This page (NASDAQ:SION) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sionna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sionna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access